1,361
-9.27%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Vital Ksk Holdings
Its shares trade on Tokyo Stock Exchange under the ticker 3151.T. It has been listed since 1 April 2009. In the fiscal year to 31 March 2026, it reported revenue of ¥610.50bn and net income of ¥7.36bn. At that date it held total assets of ¥320.57bn and shareholders' equity of ¥117.22bn.
Vital KSK Holdings, Inc. engages in the management of its group companies which are involved in the pharmaceutical business. The company is headquartered in Setagaya, Tokyo-To. The company went IPO on 2009-04-01. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 1 Apr 2009
- Employees
- 3,719
- Website
- vitalksk.co.jp ↗
Leadership
Pay as last reported
- Mr. Taisuke MuraiPresident, Chief Executive Officer, Chief Information Officer, Representative Director, since 2009
- Mr. Takeshi IchijoVice President, President of Subsidiary, Representative Director, since 2012
- Mr. Soichiro OkamotoVice President, President of Subsidiary, Representative Director, since 2018
- Mr. Akira TeramuraExecutive Officer, Director of Sales and Purchasing
- Ms. Shigemi NaitoExecutive Officer, Director of General Affairs & Human Resources
- Mr. Kiharu TakahashiExecutive Officer, Director of Business Planning
- Mr. Hiroshi HirataniExecutive Officer, Senior Director of GDP
- Mr. Kenta SatoExecutive Officer, Director of Corporate Communications
- Mr. Hideo TakedaExecutive Officer, Director of Legal Compliance
- Mr. Hiroshi YokoyamaExecutive Officer, Director in charge of Business Planning Unit, Director in charge of Corporate Communications
- Mr. Toshiyuki IguchiDirector, since 2020
- Mr. Isao KitaDirector, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Vital Ksk Holdings Inc operates in the Health Care sector with a focus on pharmaceutical wholesale through its Pharmaceutical Wholesale segment.
- The company has a significant employee base of 3,719 full-time employees in Setagaya, Tokyo-To.
- Vital Ksk Holdings Inc has been publicly traded since its IPO on April 1, 2009.
Weaknesses
- The company's business is limited to the Pharmaceutical Wholesale segment within the Health Care industry.
- Vital Ksk Holdings Inc has only one city of operation, Setagaya, Tokyo-To.
- The company's other business segments include non-core activities such as agricultural chemicals and veterinary drugs.
Opportunities
- The Pharmaceutical Wholesale segment can expand its services to hospitals and medical institutions in Setagaya.
- The company can leverage its existing employee base of 3,719 to enter new markets within the Health Care sector.
- Vital Ksk Holdings Inc can explore opportunities in the nursing care business, which is part of its other business segments.
Threats
- The company faces competition in the pharmaceutical wholesale market from other firms in the Health Care sector.
- The nursing care business, part of the other business segments, may face regulatory challenges in Japan.
- The company's reliance on the Pharmaceutical Wholesale segment could be a risk if market demand shifts.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.